Richmond Pharmacology’s New London Bridge unit offers unrivalled access to patient recruitment

Richmond Pharmacology has been settling into life in its New London Bridge Research Unit.

The new MHRA accredited unit has been actively running trials in its new surroundings since March 25th with excellent on-going patient feedback.

Our new facility is an early phase specialist unit, it is the fourth unit Richmond Pharmacology has opened and we believe it is our best to date. Richmond Pharmacology completely removed the existing facilities in the building and designed all the floors from scratch creating a better patient experience in the process. The new site has previously been used for conducting early Phase trials for more than 30 years. It is in an ideal location embedded in the King’s College University and teaching hospital campus.

“The opening of our new research facility, at what was formerly known as the Guy’s Drug Research Unit, is an exciting addition to our research capability, and will help us to provide the best possible support for our clients in their drive to increase the effectiveness and cost efficiency of developing new drugs and taking them to market.” Richmond Pharmacology CEO, Dr Jorg Taubel.

Our integrated, MHRA licensed clinical trials pharmacy is staffed by an experienced and dedicated team, supervised by two expert QPs providing quality and flexible service, GMP advice and regulatory support to our clients.

Located in centre of London, within close walking distance to key transport links, museums, historic attractions and all that London has to offer, Richmond believes the location will offer unrivalled access to patent recruitment enabling Richmond to maintain its position as Market Leaders in Combined Adaptive Early Phase Trials.

Testimonials

I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.

- Anonymous

Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.

- Anonymous

Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.

- Anonymous

Latest news

DIA, Chicago 2017

23rd Jun 2017

Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings

Read more ›

Richmond Pharmacology’s New London Bridge unit offers unrivalled access to patient recruitment

28th Apr 2017

Richmond Pharmacology has been settling into life in its New London Bridge Research Unit.

Read more ›

New CRO unit facility welcomes first overnight patients

31st Mar 2017

Richmond Pharmacology has been busy settling in their first patients at the new London Bridge site.

Read more ›

American Society for Clinical Pharmacology and Therapeutics (ASCPT)

Mar 15th 2017 | Washington, D.C

Richmond Pharmacology is attending the American Society for Clinical Pharmacology and Therapeutics (ASCPT) event in Washington DC over the next few days.

View all events ›